Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MRI Screening: a Meta-analysis

Yang, Xiao-Ping; Han, Yue-Dong; Ye, Jian-Jun; Chen, Gang; Luo, Ying; Ma, Hong-Xia; Yu, Xue-Wen; Niu, Juan-Qin; Ren, Fang-Yuan; Guo, You-Ming

추천

검색

자료유형: 학술저널

저자정보: Yang, Xiao-Ping (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Han, Yue-Dong (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Ye, Jian-Jun (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Chen, Gang (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Luo, Ying (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Ma, Hong-Xia (Department of Radiology, General Hospital of Lanzhou Command PLA) Yu, Xue-Wen (Department of Radiology, General Hospital of Lanzhou Command PLA) Niu, Juan-Qin (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Ren, Fang-Yuan (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Guo, You-Ming (Department of Radiology, General Hospital of Lanzhou Command PLA)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제12호

발행연도: 2014.1

수록면: 5,089 - 5,095 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: As a common and essential contrast medium at present, gadobenate dimeglumine has shown better performance than some other agents when applied to Breast Magnetic Resonance Imaging Screening (Breast MRI Screening). Nevertheless, reports on the diagnostic performance of these two mediums (gadobenate dimeglumine and gadopentetate dimeglumine) are not completely consistent. Objective: To assess the diagnostic value of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MRI Screening in patients suffering from breast cancer and to provide more convinced evidence to guide clinical practice in terms of appropriate contrast agents. Data Sources and Review Methods: Original articles in English and Chinese published before January 2013 were selected from available databases (The Cochrane Library, PUBMED, EMBASE, Chinese Biomedical Literature Database, Chinese Scientific Journals Full-text Database, Chinese Journal Full-text). The criteria for inclusion and exclusion were based on the standard for diagnosis tests. Meta-Disc software (Version 1.4) was used for data analysis. Then, the area under curve (AUC) of SROC and the spearman rank correlation of sensitivity against (1-specificity) were calculated. Results: Total of 17 researches involving 1934 patients were included. The pooled sensitivity of gadobenate dimeglumine and gadopentetate dimeglumine were 0.99 (0.97, 1.00) and 0.93 (0.88, 1.00) respectively. The pooled specificity for these two contrast agents were 0.924 (0.902, 0.943) and 0.838 (0.817, 0.858) respectively, and the AUC of SROC curve were 0.9781 and 0.9215 respectively. Conclusions: Gadobenate dimeglumine can be regarded as a more effective and feasible contrast medium for Breast MRI Screening. At least 5% differences in diagnostic performance are usually considered as clinically relevant.

#Gadobenate dimeglumine #gadopentetate dimeglumine #breast MRI screening #meta-analysis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요